Kratos Receives $11.2 Million Task Order Award to Support U.S. Government Satellite Communications
Mar 08, 2016 12:00 pm UTC| Business
SAN DIEGO, March 08, 2016 -- Kratos Defense Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its RT Logic subsidiary has received a new task order valued at...
Antares Pharma Reports Fourth Quarter and Full Year 2015 Operating and Financial Results
Mar 08, 2016 12:00 pm UTC| Business
Fourth Quarter and Full Year Revenues Driven by Otrexup™ and Epinephrine Auto Injector Device Sales Eighth Consecutive Quarter of Increased Product Revenue Growth EWING, N.J., March 08, 2016 -- Antares Pharma, Inc....
Neos Therapeutics Announces Date of Fourth Quarter and 2015 Fiscal Year Financial Results
Mar 08, 2016 12:00 pm UTC| Business
DALLAS and FORT WORTH, Texas, March 08, 2016 -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing and commercializing innovative extended-release (XR) products for the treatment of...
Broadwind Energy to Present at 28th Annual Roth Conference
Mar 08, 2016 12:00 pm UTC| Business
CICERO, Ill., March 08, 2016 -- Broadwind Energy, Inc. (NASDAQ:BWEN) today announced that Stephanie Kushner, CFO and Interim CEO, will present at the 28th Annual Roth Conference at the Ritz-Carlton, Laguna Niguel in...
Seabridge Gold’s Deep Kerr Inferred Resource Grows to Over One Billion Tonnes
Mar 08, 2016 12:00 pm UTC| Business
TORONTO, March 08, 2016 -- Seabridge Gold Inc. (TSX:SEA) (NYSE:SA) announced today an updated independent mineral resource estimate for the Deep Kerr Deposit at its 100%-owned KSM Project in northwestern British...
Edge Therapeutics Reports Fourth Quarter and Full-Year 2015 Financial Results
Mar 08, 2016 12:00 pm UTC| Business
BERKELEY HEIGHTS, N.J., March 08, 2016 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical stage biotechnology company developing novel hospital-based therapies in the management of acute, life threatening conditions,...
Immunomedics Develops Novel Antibody-Based Products for Autoimmune Disease and Cancer Therapy
Mar 08, 2016 12:00 pm UTC| Business
MORRIS PLAINS, N.J., March 08, 2016 -- Immunomedics, Inc., (Nasdaq:IMMU) today announced that the issuance of U.S. patent no. 9,278,129 for the Company’s new patent family “Methods of Treating Rapidly Progressive...